ORIGINAL RESEARCH
Published on 09 Jul 2026
Risk stratification model based on estimated dose of radiation to immune cells and radiotherapy-related nadir lymphocyte count for predicting the efficacy of consolidation immunotherapy in stage III non-small cell lung cancer
- 446 views
